Karim Fizazi - Researcher Profile | RDL Research Database

Publications

2 shown

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor , Johann S. de Bono , Kim N. +17 more

BACKGROUND: Metastatic castration-resistant prostate cancer remains fatal despite recent advances. Prostate-specific membrane antigen (PSMA) is highly expressed in metastatic ca...

2021 New England Journal of Medicine 2181 citations

Olaparib for Metastatic Castration-Resistant Prostate Cancer

Johann S. de Bono , Joaquı́n Mateo , Karim Fizazi +17 more

In men with metastatic castration-resistant prostate cancer who had disease progression while receiving enzalutamide or abiraterone and who had alterations in genes with a role ...

2020 New England Journal of Medicine 2067 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 4,248
Institution: Institut Gustave Roussy

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-6068-9474

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.